LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 82.85 | 17.25 | 85 | 5861 | 0.0145 | 0.2088 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 82.85 | 17.25 | 10466 | 5861 | 1.7855 | 1.1428 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 82.85 | 17.25 | 5 | 5861 | 0.0009 | -0.1370 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 82.85 | 17.25 | 11716 | 5861 | 1.9988 | 1.1717 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 84.82 | 17.25 | 77 | 5924 | 0.0130 | 0.1943 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 84.82 | 17.25 | 10696 | 5924 | 1.8055 | 1.1453 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 84.82 | 17.25 | 4 | 5924 | 0.0007 | -0.1593 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 84.82 | 17.25 | 11809 | 5924 | 1.9934 | 1.1707 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 86.79 | 17.25 | 21 | 6008 | 0.0035 | 0.0236 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 86.79 | 17.25 | 10914 | 6008 | 1.8165 | 1.1465 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 86.79 | 17.25 | 1 | 6008 | 0.0002 | -0.2863 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 86.79 | 17.25 | 11960 | 6008 | 1.9906 | 1.1699 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 88.76 | 17.25 | 71 | 6047 | 0.0117 | 0.1822 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 88.76 | 17.25 | 11070 | 6047 | 1.8304 | 1.1483 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 88.76 | 17.25 | 2 | 6047 | 0.0003 | -0.2250 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 88.76 | 17.25 | 12192 | 6047 | 2.0159 | 1.1729 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 90.74 | 17.25 | 69 | 6109 | 0.0113 | 0.1779 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 90.74 | 17.25 | 11339 | 6109 | 1.8559 | 1.1515 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 90.74 | 17.25 | 1 | 6109 | 0.0002 | -0.2856 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 90.74 | 17.25 | 12420 | 6109 | 2.0329 | 1.1748 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 92.71 | 17.25 | 58 | 6184 | 0.0094 | 0.1536 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 92.71 | 17.25 | 11545 | 6184 | 1.8669 | 1.1527 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 92.71 | 17.25 | 2 | 6184 | 0.0003 | -0.2243 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 92.71 | 17.25 | 12494 | 6184 | 2.0203 | 1.1728 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 94.68 | 17.25 | 30 | 6239 | 0.0048 | 0.0673 | MN20160310_N02 | E19 |